可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Honerjager P.Pharmacology of bipyridine phosphodiesterase inhibitors. Am Hesrt J 1991;121:1939 .
[2]Anderson JL.Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure:Results of multicenter study in the United States.Am Hesrt J 1991;121:1956.
[3]Klocke RK,et al.Effects of a twenty-fourhour milrinone infusion in patients with severe heart failure and cardiagenic shock as a function of the hemodynamic initial condition.Am Heart J 1991;121:1965.
[4]Mager G,et al.Phosphodiesterase inhibitor or adrenoreceptor stimulation:Milrinone as an alternative to dobutamine in the treatment of severe heart failure.Am Heart J 1991;121:1974.